Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Food Additives

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1758802

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1758802

Glabridin CAS 59870-68-7

PUBLISHED:
PAGES: 284 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Glabridin CAS 59870-68-7 Market to Reach US$34.5 Billion by 2030

The global market for Glabridin CAS 59870-68-7 estimated at US$27.5 Billion in the year 2024, is expected to reach US$34.5 Billion by 2030, growing at a CAGR of 3.8% over the analysis period 2024-2030. HPLC 20 percent, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$12.3 Billion by the end of the analysis period. Growth in the HPLC 40 percent segment is estimated at 3.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.5 Billion While China is Forecast to Grow at 7.3% CAGR

The Glabridin CAS 59870-68-7 market in the U.S. is estimated at US$7.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$7.0 Billion by the year 2030 trailing a CAGR of 7.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 3.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.2% CAGR.

Global "Glabridin (CAS 59870-68-7)" Market - Key Trends & Drivers Summarized

Why Is Glabridin Emerging as a High-Demand Ingredient in the Cosmetics and Health Industry?

Glabridin, a flavonoid compound extracted primarily from licorice root (Glycyrrhiza glabra), is rapidly gaining prominence in the global nutraceutical and cosmetics industries due to its potent skin-lightening, antioxidant, anti-inflammatory, and anti-aging properties. As consumer preference shifts toward naturally derived ingredients, glabridin stands out as a scientifically validated botanical alternative to synthetic actives like hydroquinone or kojic acid, especially in skincare formulations targeting hyperpigmentation, melasma, and uneven skin tone. The compound inhibits tyrosinase activity, which is responsible for melanin production, making it a go-to ingredient in brightening and whitening skincare products. In addition, glabridin is non-irritating, suitable for sensitive skin, and has demonstrated protective effects against UV-induced oxidative stress, further reinforcing its utility in anti-aging and sun care formulations. Beyond cosmetics, glabridin is also explored in functional foods and dietary supplements for its estrogenic, cardiovascular, and neuroprotective benefits. These applications are particularly relevant in markets focused on women’s health and anti-menopausal support. The growing awareness of clean-label formulations, increased R&D into herbal actives, and rising disposable income in emerging economies are further boosting demand. As natural beauty and wellness trends become mainstream across Asia-Pacific, Europe, and North America, glabridin is carving out a niche as a premium bioactive with multifunctional health and cosmetic benefits.

What Are the Key Technological and Manufacturing Trends in the Glabridin Market?

Technological innovation in the extraction, purification, and formulation of glabridin is playing a critical role in enhancing its commercial value and scalability. Traditionally extracted from licorice root using ethanol or water-alcohol solvents, glabridin now benefits from advanced supercritical CO2 extraction methods that yield higher purity and retain bioactivity more effectively. These greener and more efficient extraction techniques align with rising regulatory and consumer demand for sustainable sourcing and environmentally friendly processing. In the realm of formulation, nanoencapsulation and liposomal delivery systems are being adopted to enhance glabridin’s stability, bioavailability, and dermal absorption. These technologies help overcome challenges like low water solubility and potential degradation in topical applications. On the production side, biotech-based fermentation and plant cell culture techniques are emerging as potential alternatives to traditional farming and extraction, enabling controlled, consistent supply while minimizing environmental impact. Manufacturers are also developing standardized glabridin extracts with high active content (≥40%) to meet the purity requirements of pharmaceutical and cosmeceutical formulations. Stringent quality control and traceability mechanisms-especially for exports to Japan, South Korea, and the European Union-are increasingly being adopted to ensure compliance with safety and efficacy standards. These technological advancements not only improve product performance but also allow suppliers to meet the growing demand for high-quality, clean-label ingredients in a competitive global market.

How Are End-Use Sectors and Geographic Markets Influencing Demand Patterns?

The glabridin market is driven by strong demand from several key end-use sectors, notably cosmetics and personal care, dietary supplements, and pharmaceuticals. In cosmetics, glabridin is used extensively in skin whitening creams, anti-aging serums, sunscreens, and post-acne recovery products-making the personal care sector the largest consumer of this compound. Asia-Pacific remains the dominant market due to cultural emphasis on skin brightness and even complexion, with countries like South Korea, China, Japan, and India leading in product launches containing glabridin. Western markets, particularly in Europe and North America, are seeing increased adoption of glabridin in clean beauty and plant-based cosmeceuticals, often marketed as part of premium anti-aging and sensitive skin product lines. In the nutraceutical sector, glabridin is incorporated into supplements aimed at managing metabolic syndrome, menopause symptoms, and cardiovascular health, appealing particularly to aging populations. Pharmaceutical research is also exploring glabridin for potential applications in inflammatory disorders and hormone-related conditions, although these remain largely in the investigational stages. In terms of distribution, both B2B (bulk extract suppliers, cosmetic ingredient companies) and B2C (finished product brands) channels are expanding. Regulatory clarity around botanical extracts in China, the EU, and the U.S. is further facilitating market entry and product approvals. E-commerce growth is accelerating demand across borders, as consumers increasingly seek natural actives with clinical backing. This convergence of industry innovation and regional dynamics is reshaping how glabridin is positioned and consumed globally.

What Factors Are Fueling Growth in the Global Glabridin Market?

The growth in the glabridin (CAS 59870-68-7) market is driven by several interconnected factors tied to industry shifts, consumer behavior, and innovation in product formulation. Foremost is the rising global demand for natural, plant-derived cosmetic actives that offer effective skin benefits without the adverse effects associated with synthetic ingredients. As consumers become more ingredient-conscious, glabridin’s proven efficacy in reducing pigmentation and oxidative stress offers a strong value proposition. Second, the increasing popularity of anti-aging and skin-brightening products-particularly in Asia-Pacific and the Middle East-is fueling demand for high-efficacy botanical ingredients, with glabridin positioned as a premium option. Third, the expansion of functional food and supplement markets-driven by the aging population and interest in hormonal balance and metabolic health-is opening new use cases for glabridin in ingestible formats. On the supply side, advancements in extraction and bioengineering technologies are improving cost-efficiency and scalability, allowing manufacturers to meet rising global demand while maintaining high purity standards. The proliferation of clean-label and vegan-certified products is also creating a favorable regulatory and consumer environment for botanical ingredients like glabridin. Additionally, brand investments in R&D, clinical validation, and marketing are strengthening the credibility and visibility of glabridin-based formulations. Finally, international trade in herbal ingredients is expanding, supported by global sourcing hubs in China, India, and Central Europe. These combined drivers are positioning glabridin as a high-growth ingredient in the broader natural cosmetics and nutraceuticals market, with strong future potential across both established and emerging economies.

SCOPE OF STUDY:

The report analyzes the Glabridin CAS 59870-68-7 market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent, HPLC 98 percent); Application (Cosmetics Application, Pharmaceuticals Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • AIDP, Inc.
  • Alchem International
  • Alfa Chemicals
  • Anthony Ingredients
  • BOC Sciences
  • Botanic Innovations
  • ChemFaces
  • Chromadex, Inc.
  • CP Kelco
  • Euromed S.A.
  • FloraTech
  • Galaxy Surfactants
  • Givaudan
  • Guangxi Wuzhou Zhongheng Bio-Tech
  • Hebei Yele Biotechnology
  • Indena S.p.A.
  • Jiangxi Shenzhou Biological
  • Layn Natural Ingredients
  • Lonza Group AG
  • Natreon, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP36999

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Glabridin CAS 59870-68-7 - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Natural Skin-Lightening Agents Drives Adoption of Glabridin in Cosmetics
    • Growth in Clean Beauty and Botanical Ingredients Strengthens Market for Glabridin-Based Products
    • Scientific Research Validating Anti-Inflammatory Properties Throws Spotlight on New Therapeutic Uses
    • Expansion of Nutricosmetics Segment Accelerates Formulation of Oral Glabridin Supplements
    • Increased Consumer Preference for Non-Hydroquinone Solutions Sustains Demand for Safe Alternatives
    • Regulatory Acceptance of Plant-Based Actives Enhances Formulation Flexibility for Manufacturers
    • Growth in K-Beauty and Functional Skincare Trends Propels Use of Flavonoid-Based Ingredients
    • Limited Raw Material Sources and Cost of Purification Create Challenges in Large-Scale Production
    • Formulation Synergies with Vitamin C and Niacinamide Expand Glabridins Multi-Functional Appeal
    • E-Commerce and Indie Brand Growth Drive Inclusion in Niche Skincare Lines
    • Research into Antioxidant and Estrogenic Properties Expands Opportunities in Wellness Applications
    • High Purity Ingredient Demand from Global Markets Encourages Standardized Extraction Practices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Glabridin CAS 59870-68-7 Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Glabridin CAS 59870-68-7 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Glabridin CAS 59870-68-7 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for HPLC 20 percent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for HPLC 20 percent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for HPLC 20 percent by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for HPLC 40 percent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for HPLC 40 percent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for HPLC 40 percent by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for HPLC 60 percent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for HPLC 60 percent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for HPLC 60 percent by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for High-Performance Liquid Chromatography 90 percent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for High-Performance Liquid Chromatography 90 percent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for High-Performance Liquid Chromatography 90 percent by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for HPLC 98 percent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for HPLC 98 percent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for HPLC 98 percent by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cosmetics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Cosmetics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Cosmetics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Pharmaceuticals Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Pharmaceuticals Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Pharmaceuticals Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • JAPAN
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • CHINA
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: China 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: China 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • EUROPE
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Glabridin CAS 59870-68-7 by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Glabridin CAS 59870-68-7 by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • FRANCE
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: France 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: France 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • GERMANY
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Glabridin CAS 59870-68-7 by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Glabridin CAS 59870-68-7 by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • INDIA
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: India 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: India 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Glabridin CAS 59870-68-7 by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Glabridin CAS 59870-68-7 by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Glabridin CAS 59870-68-7 by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Glabridin CAS 59870-68-7 by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • AFRICA
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!